BG102476A - Polymorphous forms of secretagogue of growth hormone - Google Patents

Polymorphous forms of secretagogue of growth hormone

Info

Publication number
BG102476A
BG102476A BG102476A BG10247698A BG102476A BG 102476 A BG102476 A BG 102476A BG 102476 A BG102476 A BG 102476A BG 10247698 A BG10247698 A BG 10247698A BG 102476 A BG102476 A BG 102476A
Authority
BG
Bulgaria
Prior art keywords
forms
polymorphous forms
secretagogue
phenylmethoxy
propanamide
Prior art date
Application number
BG102476A
Other languages
Bulgarian (bg)
English (en)
Inventor
Jerome DRAPER
David DUBOST
Michael Kaufman
James Mccauley
Jennifer VANDRILLA
Richard Varsolona
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603361.8A external-priority patent/GB9603361D0/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of BG102476A publication Critical patent/BG102476A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Hydrogenated Pyridines (AREA)
BG102476A 1995-10-27 1998-05-21 Polymorphous forms of secretagogue of growth hormone BG102476A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US590095P 1995-10-27 1995-10-27
GBGB9603361.8A GB9603361D0 (en) 1996-02-16 1996-02-16 Polymorphic forms of a growth hormone secretagogue
PCT/US1996/016955 WO1997015574A1 (en) 1995-10-27 1996-10-23 Polymorphic forms of a growth hormone secretagogue

Publications (1)

Publication Number Publication Date
BG102476A true BG102476A (en) 1999-04-30

Family

ID=26308741

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102476A BG102476A (en) 1995-10-27 1998-05-21 Polymorphous forms of secretagogue of growth hormone

Country Status (22)

Country Link
EP (1) EP1019402A1 (no)
JP (1) JP3204266B2 (no)
KR (1) KR19990067098A (no)
CN (1) CN1067687C (no)
AU (1) AU707946B2 (no)
BG (1) BG102476A (no)
BR (1) BR9611229A (no)
CA (1) CA2235371A1 (no)
CO (1) CO4770956A1 (no)
CZ (1) CZ128098A3 (no)
EA (1) EA000528B1 (no)
EE (1) EE9800147A (no)
HK (1) HK1017894A1 (no)
HU (1) HUP9902208A3 (no)
IS (1) IS4721A (no)
NO (1) NO310556B1 (no)
NZ (1) NZ321370A (no)
PL (1) PL327511A1 (no)
SK (1) SK51398A3 (no)
TR (1) TR199800726T2 (no)
WO (1) WO1997015574A1 (no)
YU (1) YU56696A (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046333A (en) * 1996-10-25 2000-04-04 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ151495A3 (en) * 1992-12-11 1995-12-13 Merck & Co Inc Spiropiperidine derivatives, process of their preparation and a pharmaceutical composition containing thereof

Also Published As

Publication number Publication date
CZ128098A3 (cs) 1998-09-16
EA000528B1 (ru) 1999-10-28
JP3204266B2 (ja) 2001-09-04
SK51398A3 (en) 1998-12-02
JPH10512295A (ja) 1998-11-24
CO4770956A1 (es) 1999-04-30
EP1019402A1 (en) 2000-07-19
YU56696A (sh) 1999-09-27
CN1205703A (zh) 1999-01-20
NO981867D0 (no) 1998-04-24
NO310556B1 (no) 2001-07-23
MX9803351A (es) 1998-09-30
AU7468696A (en) 1997-05-15
CN1067687C (zh) 2001-06-27
WO1997015574A1 (en) 1997-05-01
EE9800147A (et) 1998-12-15
KR19990067098A (ko) 1999-08-16
NZ321370A (en) 1999-11-29
CA2235371A1 (en) 1997-05-01
EA199800335A1 (ru) 1998-12-24
BR9611229A (pt) 1999-05-25
HUP9902208A3 (en) 2001-05-28
NO981867L (no) 1998-06-29
AU707946B2 (en) 1999-07-22
PL327511A1 (en) 1998-12-21
HK1017894A1 (en) 1999-12-03
TR199800726T2 (xx) 1998-08-21
HUP9902208A2 (hu) 1999-10-28
IS4721A (is) 1998-04-21

Similar Documents

Publication Publication Date Title
CA2110670A1 (en) Spiro piperidines and homologs which promote release of growth hormone
AP1526A (en) Sertraline salts and sustained-release dosage forms of sertraline.
ZA200104396B (en) Compositions and methods for stimulating gastrointestinal motility.
HUT47390A (en) Fungicidal and plant growth regulating compositions comprising 1-azolyl-2-cyclopropyl-3-phenyl-2-propanol derivatives as active ingredient and process for producing the active ingredients and their intermediates
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
ES8402313A1 (es) Procedimiento para la obtencion de derivados de carboxilamida n-glicosilados.
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
HUT70055A (en) Process for preparing pharmaceutical compositions of immunomodulating activity containing cystine derivatives
AU5232193A (en) Spiro piperidines and homologs promote release of growth hormone
EP0813409A4 (en) TREATMENT OF DISEASES CAUSED BY THE CYTOKIN GROWTH FACTOR
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
WO2001026650A3 (en) Use of n-acyl homoserine lactones for the treatment of cardiac tachyarrhythmias, ischaemic heart disease or congestive heart failure
ZA931677B (en) Process for the preparation of beta-phenylisoserine and analogues thereof
GB9109972D0 (en) Therapeutic compounds
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
BG102476A (en) Polymorphous forms of secretagogue of growth hormone
AU558679B2 (en) Animal feed composition comprising alyl peptides
HUT48871A (en) Herbicidal compositions and process for producing substituted tetrahydrophtalimide derivatives applicable as active ingredient
BR9911756A (pt) Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto
EP1200432A4 (en) AMIDO-SPIROPIPERIDINES PROMOTING THE RELEASE OF GROWTH HORMONE
CO4930262A1 (es) Producto farmaceutico cristalino, su preparacion y uso como sustancia terapeutica
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
ATE184489T1 (de) Behandlung fehlender milchabsonderung beim menschen
MX9803316A (es) Procedimiento para preparar un secretagogo de hormona de crecimiento.